Caroline Brenner Thomsen

Delta tocotrienol in recurrent ovarian cancer. A phase II trial

Caroline Brenner Thomsen, Rikke Fredslund Andersen, Karina Dahl Steffensen et al. · Pharmacological Research · 2019 · 60 citations · Full text

Early identification of treatment benefit by methylated circulating tumor DNA in metastatic colorectal cancer

Caroline Brenner Thomsen, Torben Frøstrup Hansen, Rikke Fredslund Andersen et al. · Therapeutic Advances in Medical Oncology · 2020 · 45 citations · Full text

Early ctDNA response to chemotherapy. A potential surrogate marker for overall survival

Anders Jakobsen, Rikke Fredslund Andersen, Torben Frøstrup Hansen et al. · European Journal of Cancer · 2021 · 39 citations · Full text

Monitoring the effect of first line treatment in RAS/RAF mutated metastatic colorectal cancer by serial analysis of tumor specific DNA in plasma

Caroline Brenner Thomsen, Torben Frøstrup Hansen, Rikke Fredslund Andersen et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 36 citations · Full text

NPY Gene Methylation as a Universal, Longitudinal Plasma Marker for Evaluating the Clinical Benefit from Last-Line Treatment with Regorafenib in Metastatic Colorectal Cancer

Lars Henrik Jensen, Rene K Olesen, L. Noergaard Petersen et al. · Cancers · 2019 · 25 citations · Full text